|
|
||||||||
Journal of Lipid Research, Vol 28, 1263-1274, Copyright © 1987 by Lipid Research, Inc.
E Levy, Y Marcel, RJ Deckelbaum, R Milne, G Lepage, E Seidman, M Bendayan and CC Roy
Chylomicron retention disease is characterized by fat malabsorption,
hypocholesterolemia, normal fasting triglycerides, and marked intestinal
steatosis despite the presence of both plasma and intestinal apoprotein B.
The defect remains unknown but presumably involves the synthesis or
secretion of chylomicrons. The present investigation examines this
hypothesis by studying the biosynthesis of chylomicrons in cultured jejunal
explants and by defining the quantitative and qualitative abnormalities of
plasma lipids and of circulating lipoproteins. Following 2-3 years of a low
fat diet supplemented with medium chain triglycerides, six patients with
chylomicron retention disease had significantly higher triglyceride (TG)
levels coupled with a decrease in both free (FC) and esterified cholesterol
(EC) as well as in essential fatty acids and phospholipids (PL) when
compared to healthy controls. The low total plasma cholesterol was largely
accounted for by low levels of both low density (LDL) and high density
lipoprotein (HDL) cholesterol. VLDL and LDL were characterized by a
diminished percentage of CE with an increase of TG while HDL contained
relatively more FC as well as PL and less CE. The diameter of VLDL was
larger whereas those of LDL and HDL were smaller than in normal controls.
Jejunal explants, when incubated with [14C]palmitate, were capable of
normal biosynthesis of TG, diglycerides, PL, and CE. These lipids, however,
except for PL, were retained in the tissue and could not be secreted into
the culture medium. Incubation of intestinal biopsies with [3H]leucine and
[14C]mannose resulted in normal protein synthesis and reduced
glycosylation. The presence of intestinal apoB-48 was confirmed by
immunoblot using 2D8 antibodies. These data suggest that the intestinal
defect in this disease results from a disorder of the final assembly of
chylomicrons or in the mechanism of their exocytosis.
ARTICLES
Intestinal apoB synthesis, lipids, and lipoproteins in chylomicron retention disease [published erratum appears in J Lipid Res 1988 Jan;29(1):119]
Department of Pediatrics, Hopital Sainte-Justine, Montreal, Quebec, Canada.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. G. Alb Jr., S. E. Phillips, L. R. Wilfley, B. D. Philpot, and V. A. Bankaitis The pathologies associated with functional titration of phosphatidylinositol transfer protein {alpha} activity in mice J. Lipid Res., August 1, 2007; 48(8): 1857 - 1872. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Peretti, C. C. Roy, E. Drouin, E. Seidman, P. Brochu, G. Casimir, and E. Levy Abnormal intracellular lipid processing contributes to fat malabsorption in cystic fibrosis patients Am J Physiol Gastrointest Liver Physiol, April 1, 2006; 290(4): G609 - G615. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wopereis, D. J. Lefeber, E. Morava, and R. A. Wevers Mechanisms in Protein O-Glycan Biosynthesis and Clinical and Molecular Aspects of Protein O-Glycan Biosynthesis Defects: A Review Clin. Chem., April 1, 2006; 52(4): 574 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Stan, M. Lambert, E. Delvin, G. Paradis, J. O'Loughlin, J. A. Hanley, and E. Levy Intestinal fatty acid binding protein and microsomal triglyceride transfer protein polymorphisms in French-Canadian youth J. Lipid Res., February 1, 2005; 46(2): 320 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zoltowska, E. Ziv, E. Delvin, D. Sinnett, R. Kalman, C. Garofalo, E. Seidman, and E. Levy Cellular Aspects of Intestinal Lipoprotein Assembly in Psammomys Obesus: A Model of Insulin Resistance and Type 2 Diabetes Diabetes, October 1, 2003; 52(10): 2539 - 2545. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Levy, D. Menard, E. Delvin, S. Stan, G. Mitchell, M. Lambert, E. Ziv, J. C. Feoli-Fonseca, and E. Seidman The Polymorphism at Codon 54 of the FABP2 Gene Increases Fat Absorption in Human Intestinal Explants J. Biol. Chem., October 19, 2001; 276(43): 39679 - 39684. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Levy, S. Stan, C. Garofalo, E. E. Delvin, E. G. Seidman, and D. Menard Immunolocalization, ontogeny, and regulation of microsomal triglyceride transfer protein in human fetal intestine Am J Physiol Gastrointest Liver Physiol, April 1, 2001; 280(4): G563 - G571. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Levy, Y. Rizwan, L. Thibault, G. Lepage, S. Brunet, L. Bouthillier, and E. Seidman Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn disease Am. J. Clinical Nutrition, March 1, 2000; 71(3): 807 - 815. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Levy, J.-F. Beaulieu, E. Delvin, E. Seidman, W. Yotov, J.-R. Basque, and D. Ménard Human crypt intestinal epithelial cells are capable of lipid production, apolipoprotein synthesis, and lipoprotein assembly J. Lipid Res., January 1, 2000; 41(1): 12 - 22. [Abstract] [Full Text] |
||||
![]() |
A. H. Dannoura, N. Berriot-Varoqueaux, P. Amati, V. Abadie, N. Verthier, J. Schmitz, J. R. Wetterau, M.-E. Samson-Bouma, and L. P. Aggerbeck Anderson's Disease : Exclusion of Apolipoprotein and Intracellular Lipid Transport Genes Arterioscler. Thromb. Vasc. Biol., October 1, 1999; 19(10): 2494 - 2508. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Coussons, C. S. Bourgeois, D. Wiggins, and G. F. Gibbons Selective Recruitment of ApoB-48 for the Assembly of VLDL in Rat Triacylglycerol-Enriched Hepatocytes Arterioscler. Thromb. Vasc. Biol., July 1, 1996; 16(7): 889 - 897. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |